What are the preferred inotropes/vasopressors agents for cardiogenic shock in situations with and without LVOT obstruction?
Is there literature to support superiority of levophed over dobutamine, or vice versa?
Answer from: at Community Practice
Randomized evidence to support an answer to this question is lacking.
As the question recognizes, "cardiogenic shock" encompasses a diversity of anatomic and hemodynamic substrates of disease. Left ventricular outflow tract obstruction, which may be fixed or dynamic, a baseline feature or acutely a...